Published in The Journal of Physiology · View the paper (DOI)
Researchers have successfully repurposed two existing medications to reduce the severity of sleep apnoea in people by at least 30 per cent. The study showed that reboxetine and butylbromide increased muscle activity around participants' airways, reducing the number of breathing stoppages and improving oxygen intake.
Coverage from 2 institutions
- New solution for sleep apnoea Flinders University · Jul 2, 2021 · first to report
- Researchers reduce severity of sleep apnoea by at least 30 per cent The Physiological Society · Jul 2, 2021